Aravive's Total Assets for the quarter that ended in Sep. 2023 was $13.05 Mil.
During the past 12 months, Aravive's average Total Assets Growth Rate was -68.50% per year.
During the past 3 years, the average Total Assets Growth Rate was -20.70% per year.
During the past 5 years, the average Total Assets Growth Rate was -11.00% per year.
During the past 10 years, the average Total Assets Growth Rate was 21.10% per year.
During the past 11 years, Aravive's highest 3-Year average Total Assets Growth Rate was 56.70%. The lowest was -20.70%. And the median was 33.65%.
Total Assets is connected with ROA %. Aravive's annualizedROA % for the quarter that ended in Sep. 2023 was 437.81%. Total Assets is also linked to Revenue through Asset Turnover. Aravive's Asset Turnover for the quarter that ended in Sep. 2023 was 0.14.
Aravive Total Assets Historical Data
The historical data trend for Aravive's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
Aravive's Total Assets for the fiscal year that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note:
The Net Income data used here is four times the quarterly (Sep. 2023) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Aravive's Asset Turnover for the quarter that ended in Sep. 2023 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Aravive Total Assets Related Terms
Thank you for viewing the detailed overview of Aravive's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Aravive Inc is a clinical-stage biopharmaceutical company. It focuses on developing treatments designed to halt the progression of life-threatening diseases, including cancer and fibrosis. The company pipeline product Batiraxcept (formerly AVB-500) which is an ultra-high affinity decoy protein that binds to GAS6 and thereby prevents AXL signaling to inhibit metastasis and tumor growth and restore sensitivity to anti-cancer agents. Batiraxcept is currently being evaluated in multiple clinical trials.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ARAV has been successfully added to your 